Monopar Therapeutics

Share on: 
Description: 

Monopar Therapeutics is a biopharmaceutical company focused on developing drugs and drug combinations to improve clinical outcomes for cancer patients. Monopar currently has three compounds in development: Validive® (clonidine mucobuccal tablet; clonidine MBT).

Location(s): 
Wilmette IL
United States